Skip to content

Precigen PGEN Interest coverage

Interest coverage at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
75.6×-4.5×
Gilead Sciences logo
Gilead SciencesGILD
10.3×+2.0×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-49.3×-20.0×
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-9.3×+1.9×
Arrowhead Research logo
Arrowhead ResearchARWR
-2.4×+0.9×
PVL
Palvella TherapeuticsPVLA
-174.9×

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

Based on trailing twelve months.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's interest coverage?
Precigen (PGEN) reported interest coverage of -22,521.4× in Q1 2025.
How has Precigen's interest coverage changed year-over-year?
Precigen's interest coverage decreased by 7211.8% year-over-year, from -308× to -22,521.4×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.